Aorta blocking / counterpulsation device and assembly
Patent Information
- Application Number
- CN202411410127.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-10
- Publication Date
- 2024-11-26
AI Technical Summary
Existing aortic occlusion devices are difficult to control the injection pressure, which may lead to local vascular damage, and are limited in remote areas or first-line medical scenarios, and cannot achieve both aortic occlusion and counterpulse functions, which limits the use of critically ill patients. Treatment effect.
Aortic blockade/counterpulse device is designed, using a pressure-regulated telescopic structure and artificial venous valve, which can achieve rapid release and recovery through elastic support and suspension. Combined with the transversely installed counterpulse function, it can be used in the aorta. Blood flow blocking and counter-pulsing are achieved without water injection.
It achieves rapid and simple aortic occlusion and counter-pulse effects, improves the success rate of treatment for critically ill patients, avoids local vascular damage, and reduces cardiac afterload under complex conditions, and improves coronary perfusion.
Smart Images

Figure CN119015595A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to medical equipment, in particular to an aortic occlusion / counterpulsation device and a component. Background Art
[0002] The abdominal aorta is the largest artery in the human body, with a large blood flow. Due to its special anatomical location, when a patient has a massive aortic hemorrhage, conventional hemostasis methods such as compression cannot effectively stop the bleeding. Intraaortic balloon occlusion is an effective hemostasis method for aortic trauma. Its principle is to use intracavitary technology to place an expandable balloon into the proximal end of the aortic injury, fill the balloon and block the aortic blood flow. In clinical medicine, water-filled balloons are often used to complete this operation. However, it has the following defects:
[0003] The water injection pressure of the water-injected balloon is difficult to control. If the pressure is too low, it is difficult to effectively block the aorta, and if the pressure is too high, it may cause local vascular damage.
[0004] The placement of the water-filled balloon has requirements for equipment and technology, which limits its application scenarios, such as remote areas or front-line medical scenarios;
[0005] There is a time limit for blocking blood flow with a water-filled balloon. The placement time is limited to 30 minutes in the abdominal trauma area and 90 minutes in the pelvic trauma area. Long-term aortic occlusion will cause ischemia of important organs and secondary ischemia-related damage. At the same time, this technology cannot be used in some special cases, such as chest or neck trauma, which brings many restrictions to trauma treatment.
[0006] Intra-aortic balloon pump (IABP) is a method of mechanical circulatory assistance, which basically involves placing a balloon catheter in the descending aorta and connecting it to an external control device to inflate and deflate it as the heart relaxes and contracts, thereby increasing cardiac output and improving coronary artery perfusion. Specifically, when the heart contracts and the aortic valve opens, the balloon is deflated quickly, creating a cavity effect, thereby reducing afterload, increasing cardiac output, improving blood perfusion of important organs, increasing urine output, and accompanied by a decrease in heart rate; and when the heart relaxes and the aortic valve closes, the balloon is inflated quickly, increasing arterial diastolic pressure and thus increasing coronary artery perfusion. In clinical practice, the aortic counterpulsation balloon needs to be connected to a dedicated device to control the filling and emptying of the balloon at different times in the cardiac cycle, thereby achieving the effect of aortic counterpulsation.
[0007] Both devices are deployed in the aorta, and their placement procedures are similar, but there is currently no product that combines aortic occlusion and aortic counterpulsation. In the actual treatment of critically ill patients, patients with aortic injury may suffer from heart failure. A device that can be easily released and block aortic blood flow to reduce blood loss, while reducing cardiac afterload and increasing diastolic pressure to improve coronary artery perfusion through programmable counterpulsation can cope with such complex situations, thereby improving the success rate of treatment. Summary of the invention
[0008] The present invention aims to overcome the above-mentioned defects and provide a device which is quick to operate, simple in structure, does not require water injection and other operations, and can achieve both aortic occlusion and counterpulsation effect.
[0009] The present invention provides an aortic blocking / counterpulsation device, which can be quickly released and recovered in the aorta without the need for an input medium and can achieve a counterpulsation effect, and is characterized in that: it comprises a blocking device frame and a counterpulsation functional part;
[0010] Wherein, the blocking device frame is a pressure-regulated telescopic structure;
[0011] The counterpulsation functional part is installed transversely on the blocking device frame, which can block the downstream blood flow and realize the blood flow counterpulsation.
[0012] Furthermore, the present invention provides an aortic occlusion / counterpulsation device, which is also characterized by:
[0013] The blocking device frame is composed of a plurality of radially arranged elastic supporting members.
[0014] Furthermore, the present invention provides an aortic occlusion / counterpulsation device, which is also characterized by:
[0015] The blocking device frame pops out in an umbrella shape when there is no pressure, and can be retracted when there is pressure.
[0016] Furthermore, the present invention provides an aortic occlusion / counterpulsation device, which is also characterized by:
[0017] The blocking device frame is composed of an elastic frame;
[0018] The elastic frame is elastically expanded to form a cage-like spherical, elliptical, spindle-shaped, or pyramidal shape under no pressure, and is compressed into a shape that can be accommodated in the sheath tube under pressure.
[0019] Furthermore, the present invention provides an aortic occlusion / counterpulsation device, which is also characterized by:
[0020] The end of the blocking device frame is detachably connected with a push rod.
[0021] Furthermore, the present invention provides an aortic occlusion / counterpulsation device, which is also characterized by:
[0022] A hanging piece is provided at the end of the blocking device frame;
[0023] The above-mentioned hanging member is connected with a recovery workpiece;
[0024] The above-mentioned recovery workpiece is a component that can pass through the sheath tube and directly reach the wound surface.
[0025] Furthermore, the present invention provides an aortic occlusion / counterpulsation device, which is also characterized by:
[0026] The counterpulsation functional part is an artificial venous valve installed in reverse.
[0027] Furthermore, the present invention provides an aortic occlusion / counterpulsation device, which is also characterized by:
[0028] An adjustment control fixing end is provided at the opening position of at least one valve of the artificial venous valve;
[0029] The fixed end of the control panel is connected to a control tool;
[0030] The regulating tool is a component that can pass through the sheath tube and directly reach the wound surface.
[0031] In addition, the present invention also provides an aortic occlusion / counterpulsation device assembly, characterized in that it comprises the above-mentioned aortic occlusion / counterpulsation device, a guide wire and a sheath;
[0032] Wherein, the guide wire is used to locate the installation position of the aortic occlusion / counterpulsation device;
[0033] The above-mentioned aortic occlusion / counterpulsation device reaches the installation position through the sheath. BRIEF DESCRIPTION OF THE DRAWINGS
[0034] Figure 1 , a schematic diagram of the structure of an aortic occlusion / counterpulsation device provided in this embodiment;
[0035] Figure 2 , a schematic diagram of the structure of an aortic occlusion / counterpulsation device provided by a variation of this embodiment;
[0036] Figure 3 , a schematic diagram of the structure of an aortic occlusion / counterpulsation device provided by a variation of this embodiment;
[0037] Figure 4 , a schematic diagram of the structure of an aortic occlusion / counterpulsation device provided by a variation of this embodiment;
[0038] Figure 5, a schematic diagram of the structure of an aortic occlusion / counterpulsation device provided by a variation of this embodiment;
[0039] Figure 6 , a schematic diagram of the structure of an aortic occlusion / counterpulsation device provided by a variation of this embodiment;
[0040] Figure 7 , a schematic diagram of a method for using an aortic occlusion / counterpulsation device provided in this embodiment; DETAILED DESCRIPTION
[0041] The present invention is capable of various modifications and various embodiments, and therefore specific embodiments are illustrated and described in the accompanying drawings. However, this is not intended to limit the present invention to specific implementations, but should be understood to include all modifications, equivalents, and even substitutes that fall within the concept and technical scope of the present invention.
[0042] like Figure 1 As shown, this embodiment provides an aortic occlusion / counterpulsation device 10, comprising an occlusion device frame 100 and a counterpulsation functional component 200;
[0043] The blocking device frame 100 is a pressure-controlled telescopic structure. Specifically, the blocking device frame is made of elastic material. In its initial state, it is compressed and stored in the tube. When it is pushed out of the tube, it undergoes elastic deformation due to the self-restoration of the elastic material, and supports the inner wall of the blood vessel according to the size of the blood vessel in which it is located.
[0044] In this embodiment, the blocking device frame 100 is composed of a plurality of radially arranged elastic support members, which pop out in an umbrella shape when there is no pressure and can be retracted when under pressure;
[0045] The end of the blocking device frame 100 is provided with a hanging member 110;
[0046] The hanging member may be connected to a thread-shaped recovery workpiece (such as Figure 7 40 of 40);
[0047] The recovery workpiece can pass through the sheath tube directly to reach the wound surface, so that the opened blocking device frame can be pulled into the sheath tube outside the wound to achieve the effect of closing and restoring the original state.
[0048] The counterpulsation function part 200 is installed horizontally in the middle of the blocking device frame 100, and can block the downstream blood flow and realize the blood flow counterpulsation mechanism. Specifically, it is as follows Figure 2 As shown, the reversely installed artificial venous valve (i.e., the existing artificial venous valve is directly fixed to the cross-section of the frame by bonding, weaving, etc.) or the one-way valve composed of multiple valves, both of which have the shape of multiple valves 210.
[0049] When using an artificial bionic venous valve, it can imitate the working principle of the venous valve, automatically opening and closing during the pulsation of the blood vessels, thereby achieving the effect of blocking the downstream blood and counterpulsating the reverse flow of blood. This does not affect the purpose of blocking when the aorta ruptures, and can maintain the necessary blood supply through blood counterpulsation.
[0050] In addition, considering the need to regulate the amount of blood flow inflow to increase it at a specific time during clinical procedures, such as Figure 3 As shown, in this case, the valve is also modified, and a hole 211 (fixed end of the adjustment control) is punched on each membrane of the valve, and then a control tool 221 is inserted into the through hole 211;
[0051] The head end of the regulating tool is limited to the upper surface of the valve, and the tail end is connected to a control line 50 passing through the through hole 211. The control line 50 can directly reach the wound surface through the sheath, so that the physician can perform on-site control.
[0052] In another test example, the following Figure 4-6 The blocking device frame 100 shown as being composed of an elastic frame can be a cage-shaped structure such as a sphere, an ellipse, a spindle, or a pyramid. Such a structure can also be in a cage-shaped form that can support blood vessels due to elastic expansion under no pressure (i.e., when ejected from the sheath tube), and can be compressed into a shape that can be accommodated in the sheath tube (e.g., when accommodated in the sheath tube) under pressure (i.e., when accommodated in the sheath tube). Figure 7 ).
[0053] The components used in conjunction with the above-mentioned aortic occlusion / counterpulsation device also include a guide wire (not shown, i.e., a filament, consistent with a traditional guide wire), a sheath 20 and a push rod 30;
[0054] The guidewire is used to locate the installation position of the aortic clamping / counterpulsation device;
[0055] After the aortic occlusion / counterpulsation device reaches the installation position through the sheath, it is pushed out of the sheath via the push rod to achieve release.
[0056] Although the above description is centered on the embodiment, it is only an example and does not limit the present invention. It is clear to those skilled in the art that various modifications and applications not illustrated above can be made within the scope of the essential characteristics of the present embodiment. For example, each component specifically shown in the embodiment can be implemented after being modified. Moreover, various differences related to such modifications and applications should be interpreted as being included in the scope of the present invention as defined in the attached claims.
Claims
1. An aortic occlusion / counterpulsation device, characterized in that: It comprises a blocking device frame and a counterpulsation functional part; wherein the blocking device frame is a pressure-regulated telescopic structure; The counterpulsation functional part is a mechanism installed transversely on the blocking device frame and can block the downstream blood flow to achieve blood flow counterpulsation.
2. An aortic occlusion / counterpulsation device as claimed in claim 1, characterized in that: The blocking device frame is composed of a plurality of radially arranged elastic supporting members.
3. An aortic occlusion / counterpulsation device as claimed in claim 2, characterized in that: The blocking device frame can pop out in an umbrella shape when there is no pressure, and can be retracted when there is pressure.
4. The aortic occlusion / counterpulsation device according to claim 1, characterized in that: The blocking device frame is composed of an elastic frame; The elastic frame is in a cage-like spherical, elliptical, spindle, or pyramidal shape due to elastic expansion in the absence of pressure, and is compressed into a shape that can be accommodated in the sheath tube under pressure.
5. The aortic occlusion / counterpulsation device according to claim 1, characterized in that: The end of the blocking device frame is provided with a hanging piece; The hanging member is connected with a recovery workpiece; The recovery workpiece is a component that can pass through the sheath tube and directly reach the wound surface.
6. The aortic occlusion / counterpulsation device according to claim 1, characterized in that: The counterpulsation functional part is a reversely installed artificial venous valve or a one-way valve composed of multiple valves.
7. An aortic occlusion / counterpulsation device as claimed in claim 6, characterized in that: The opening position of at least one valve of the artificial venous valve or the one-way valve composed of multiple valves is provided with an adjustment control fixing end; The fixed end of the adjustment control is connected to an adjustment tool; The regulating tool is a component that can pass through the sheath tube and directly reach the wound surface.
8. An aortic occlusion / counterpulsation device assembly, characterized in that: Comprising the aortic clamping / counterpulsation device as described in any one of claims 1 to 7, a guide wire and a sheath; Wherein, the guide wire locates the installation position of the aortic occlusion / counterpulsation device; The aortic occlusion / counterpulsation device reaches the installation position through the sheath.
9. An aortic occlusion / counterpulsation device assembly as claimed in claim 8, characterized in that: Also included is a propulsion rod; The pushing rod pushes the blocking device frame out of the sheath tube.
